BeOne Medicines Logo

BeOne Medicines

🇨🇭
06160
CH1391448177

BeOne Medicines, an innovative pharmaceutical company headquartered in Switzerland, is dedicated to the research and development of novel therapies. The company focuses on biotechnological approaches to create groundbreaking medicines for specific diseases, aiming to sustainably improve the quality of life for patients worldwide. Its expertise lies in the discovery and clinical development of pioneering pharmaceutical solutions.

Next Quarterly Earnings

Thursday, August 27, 2026
CW 35
Pre-Market
In 46 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on July 30, 2026

Stock Price

Frequently asked questions

When will BeOne Medicines report its next quarterly earnings?

BeOne Medicines is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did BeOne Medicines last report quarterly earnings?

BeOne Medicines last reported quarterly earnings on 5/6/2026 (Q2 2026). Earnings per share (EPS) came in at 1.18 HKD.

How do I add the BeOne Medicines earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:HK$0.97
Actual:
Q2 2026
Beat
Estimate:HK$0.65
Actual:HK$1.18
Difference:+HK$0.53
Q1 2026
Missed
Estimate:HK$0.75
Actual:HK$0.36
Difference:-HK$0.39

Company Information

Name
BeOne Medicines
Ticker Symbol
06160
ISIN
CH1391448177
Country
🇨🇭
Switzerland
Sector
Healthcare